Journal article
Exploring the Public Health and Social Implications of Future Curative Hepatitis B Interventions
J Wallace, J Richmond, J Howell, B Hajarizadeh, J Power, C Treloar, PA Revill, B Cowie, S Wang, M Stoové, A Pedrana, M Hellard
Viruses | MDPI | Published : 2022
DOI: 10.3390/V14112542
Abstract
Hepatitis B is a significant global health issue where the 296 million people estimated to live with the infection risk liver disease or cancer without clinical intervention. The World Health Organization has committed to eliminating viral hepatitis as a public health threat by 2030, with future curative hepatitis B interventions potentially revolutionizing public health responses to hepatitis B, and being essential for viral hepatitis elimination. Understanding the social and public health implications of any cure is imperative for its successful implementation. This exploratory research, using semi-structured qualitative interviews with a broad range of professional stakeholders identifies..
View full abstractGrants
Funding Acknowledgements
J.W., J.H. and M.H. receive fellowship support from the Australian National Health and Medical Research Council. J.H. is supported by a University of Melbourne Faculty Trust Fellowship. C.T. has received speaker fees from Gilead and Abbvie, and research funding (for an unrelated project) from Merck. P.A.R. received research funding from Gilead Sciences. M.S. receives investigator-initiated funding from Gilead Sciences, AbbVie, and Bristol Myers Squibb for research unrelated to this work. A.P. has received speaker fees from Gilead Sciences and receives funding from Gilead Sciences, AbbVie, and Merck for investigator-initiated research. M.H. has received funding from Gilead Sciences and AbbVie for investigator-initiated research. The authors gratefully acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program received by the Burnet Institute.